The Prognostic Utility of Plasma NGAL Levels in ST Segment Elevation in Myocardial Infarction Patients
Yazarlar (5)
Prof. Dr. Ahmet AVCI Zonguldak Bülent Ecevit Üniversitesi, Türkiye
Prof. Dr. Bahadır Öztürk Selçuk Üniversitesi, Türkiye
Prof. Dr. Kenan Demir Selçuk Üniversitesi, Türkiye
Fikret Akyürek
Prof. Dr. Bülent Behlül Altunkeser Selçuk Üniversitesi, Türkiye
| Makale Türü | Özgün Makale (Uluslararası alan indekslerindeki dergilerde yayınlanan tam makale) | ||
| Dergi Adı | Advances in Preventive Medicine | ||
| Dergi ISSN | 2090-3480 | ||
| Dergi Tarandığı Indeksler | pubmed | ||
| Makale Dili | İngilizce | Basım Tarihi | 08-2020 |
| Cilt / Sayı / Sayfa | 2020 / 1 / 1–7 | DOI | 10.1155/2020/4637043 |
| Makale Linki | https://www.hindawi.com/journals/apm/2020/4637043/ | ||
| Özet |
| Introduction. Plasma neutrophil gelatinase‐associated lipocalin (NGAL) levels in acute myocardial infarction (AMI) patients are markedly higher. In addition, plasma NGAL levels were increased in patients with acute and chronic heart failure as a complication of myocardial infarction. In this study, we investigated whether there is a difference between the prognostic use of plasma NGAL levels in ST‐elevation myocardial infarction (STEMI) patients with preserved and reduced left ventricular ejection fraction (LVEF). Methods. 235 consecutive STEMI patients were enrolled in the study. Patients were divided into groups according to LVEF. Plasma NGAL, troponin I, creatine kinase MB (CKMB), and C‐reactive protein (CRP) were measured. Finally, the study population examined with 34 reduced LVEF and 34 preserved LVEF consisted of a total of 68 patients (12 females; mean age, 61.5 ± 14.7). All patients were … |
| Anahtar Kelimeler |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Google Scholar | 20 |